$UTMD
Utah Medical Products Inc

2022 Q3 Form 10-Q Financial Statement

#000181188422000012 Filed on August 12, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $12.96M $13.43M $12.32M
YoY Change 3.05% 6.54% 12.44%
Cost Of Revenue $4.769M $5.277M $4.790M
YoY Change 6.0% 9.5% 19.15%
Gross Profit $8.186M $8.151M $7.533M
YoY Change 1.4% 4.7% 8.39%
Gross Profit Margin 63.19% 60.7% 61.13%
Selling, General & Admin $2.933M $2.959M $2.888M
YoY Change 2.98% 2.32% -1.43%
% of Gross Profit 35.83% 36.3% 38.34%
Research & Development $112.0K $135.0K $123.0K
YoY Change -11.81% 5.47% -5.38%
% of Gross Profit 1.37% 1.66% 1.63%
Depreciation & Amortization $1.732M $1.764M $1.795M
YoY Change -4.78% -4.13% -1.37%
% of Gross Profit 21.16% 21.64% 23.83%
Operating Expenses $3.045M $3.094M $3.011M
YoY Change 2.35% 2.45% -1.6%
Operating Profit $5.141M $5.057M $4.522M
YoY Change 0.84% 6.13% 16.25%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $198.0K $142.0K $8.000K
YoY Change 235.59% 136.67% -20.0%
Pretax Income $5.339M $5.199M $4.530M
YoY Change 3.53% 7.75% 16.15%
Income Tax $1.059M $1.096M $996.0K
% Of Pretax Income 19.84% 21.08% 21.99%
Net Earnings $4.280M $4.103M $3.534M
YoY Change 1.76% 19.76% 16.87%
Net Earnings / Revenue 33.04% 30.56% 28.68%
Basic Earnings Per Share $1.18 $1.13 $0.97
Diluted Earnings Per Share $1.18 $1.12 $964.3K
COMMON SHARES
Basic Shares Outstanding 3.625M shares 3.643M shares 3.655M shares
Diluted Shares Outstanding 3.634M shares 3.650M shares 3.665M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $69.51M $66.22M $65.87M
YoY Change 8.07% 11.29% 17.63%
Cash & Equivalents $69.51M $66.22M $65.87M
Short-Term Investments
Other Short-Term Assets $387.0K $453.0K $520.0K
YoY Change 3.75% 26.89% 4.0%
Inventory $8.310M $7.338M $7.367M
Prepaid Expenses
Receivables $6.034M $4.938M $5.720M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $84.24M $78.95M $79.48M
YoY Change 11.07% 11.85% 19.34%
LONG-TERM ASSETS
Property, Plant & Equipment $9.852M $10.17M $11.00M
YoY Change -9.87% -8.93% -0.93%
Goodwill $12.87M $13.40M
YoY Change
Intangibles $11.04M $13.21M
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $34.17M $37.20M $40.32M
YoY Change -22.17% -19.5% -15.64%
TOTAL ASSETS
Total Short-Term Assets $84.24M $78.95M $79.48M
Total Long-Term Assets $34.17M $37.20M $40.32M
Total Assets $118.4M $116.1M $119.8M
YoY Change -1.12% -0.55% 4.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.289M $818.0K $1.454M
YoY Change 25.63% -31.03% 81.75%
Accrued Expenses $4.980M $3.621M $4.644M
YoY Change 24.84% 11.59% 25.51%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.269M $4.439M $6.098M
YoY Change 25.0% 0.18% 32.57%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.675M $1.675M $2.328M
YoY Change -34.03% -22.35% -3.0%
Total Long-Term Liabilities $1.675M $1.675M $2.328M
YoY Change -34.03% -22.35% -3.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.269M $4.439M $6.098M
Total Long-Term Liabilities $1.675M $1.675M $2.328M
Total Liabilities $10.23M $8.678M $10.64M
YoY Change 4.66% -7.96% 11.95%
SHAREHOLDERS EQUITY
Retained Earnings $122.5M $119.3M
YoY Change
Common Stock $94.00K $36.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $108.2M $107.5M $109.2M
YoY Change
Total Liabilities & Shareholders Equity $118.4M $116.1M $119.8M
YoY Change -1.12% -0.55% 4.72%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income $4.280M $4.103M $3.534M
YoY Change 1.76% 19.76% 16.87%
Depreciation, Depletion And Amortization $1.732M $1.764M $1.795M
YoY Change -4.78% -4.13% -1.37%
Cash From Operating Activities $5.589M $4.832M $5.046M
YoY Change -6.71% 2.92% -8.75%
INVESTING ACTIVITIES
Capital Expenditures -$321.0K -$222.0K -$237.0K
YoY Change 316.88% 4.72% 2270.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$321.0K -$222.0K -$237.0K
YoY Change 316.88% 4.72% 2270.0%
FINANCING ACTIVITIES
Cash Dividend Paid $0.00
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.032M -3.551M 19.00K
YoY Change 21.41% 243.09% -102.0%
NET CHANGE
Cash From Operating Activities 5.589M 4.832M 5.046M
Cash From Investing Activities -321.0K -222.0K -237.0K
Cash From Financing Activities -1.032M -3.551M 19.00K
Net Change In Cash 4.236M 1.059M 4.828M
YoY Change -16.35% -69.29% 5.65%
FREE CASH FLOW
Cash From Operating Activities $5.589M $4.832M $5.046M
Capital Expenditures -$321.0K -$222.0K -$237.0K
Free Cash Flow $5.910M $5.054M $5.283M
YoY Change -2.6% 3.0% -4.64%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3624932 shares
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
66224000 usd
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60974000 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4938000 usd
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3625000 shares
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5132000 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
7338000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
6596000 usd
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3625000 shares
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
453000 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
456000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
78953000 usd
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
11000 shares
CY2021Q4 us-gaap Assets Current
AssetsCurrent
73158000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10171000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10618000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
420000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
449000 usd
CY2022Q2 us-gaap Goodwill
Goodwill
13396000 usd
CY2021Q4 us-gaap Goodwill
Goodwill
14098000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
52560000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
55865000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
39351000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
38552000 usd
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
13209000 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
17313000 usd
CY2022Q2 us-gaap Assets
Assets
116149000 usd
CY2021Q4 us-gaap Assets
Assets
115636000 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
818000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
761000 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3621000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2984000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
4439000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3745000 usd
CY2022Q2 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
1707000 usd
CY2021Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
2105000 usd
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1675000 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1675000 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
368000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
396000 usd
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3655000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3655000 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
36000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
37000 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Before Tax1
AccumulatedOtherComprehensiveIncomeLossBeforeTax1
-11858000 usd
CY2022Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
489000 usd
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
577000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
8678000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
8498000 usd
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-12575
dei Entity Registrant Name
EntityRegistrantName
UTAH MEDICAL PRODUCTS INC
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
UT
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0342734
dei Entity Address Address Line1
EntityAddressAddressLine1
7043 South 300 West
dei Entity Address City Or Town
EntityAddressCityOrTown
Midvale
dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84047
dei City Area Code
CityAreaCode
801
dei Local Phone Number
LocalPhoneNumber
566-1200
dei Security12b Title
Security12bTitle
Common stock, $0.01 par value
dei Trading Symbol
TradingSymbol
UTMD
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Document Type
DocumentType
10-Q
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Before Tax1
AccumulatedOtherComprehensiveIncomeLossBeforeTax1
-9054000 usd
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
0 usd
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
841000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
119293000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
115314000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
107471000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
107138000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
116149000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
115636000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13428000 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12604000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25752000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23568000 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5277000 usd
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4819000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10069000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8836000 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
8151000 usd
CY2021Q2 us-gaap Gross Profit
GrossProfit
7785000 usd
us-gaap Gross Profit
GrossProfit
15683000 usd
us-gaap Gross Profit
GrossProfit
14732000 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2959000 usd
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2892000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5846000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5821000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
135000 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
128000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
258000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
259000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
3094000 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
3020000 usd
us-gaap Operating Expenses
OperatingExpenses
6104000 usd
us-gaap Operating Expenses
OperatingExpenses
6080000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
5057000 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
4765000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
9579000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
8652000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
142000 usd
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
60000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
150000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
71000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5199000 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4825000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9729000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8723000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1096000 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1399000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2091000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2273000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
4103000 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
3426000 usd
us-gaap Profit Loss
ProfitLoss
7638000 usd
us-gaap Profit Loss
ProfitLoss
6450000 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.13
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.94
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.09
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.77
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.12
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.94
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.76
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3643000 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3646000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3649000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3645000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3650000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3655000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3658000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3656000 shares
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2298000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
49000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2804000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-5000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1805000 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3475000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4834000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6445000 usd
us-gaap Profit Loss
ProfitLoss
7638000 usd
us-gaap Profit Loss
ProfitLoss
6450000 usd
us-gaap Depreciation
Depreciation
302000 usd
us-gaap Depreciation
Depreciation
325000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3257000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3335000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
26000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
8000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
26000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
21000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-286000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
22000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
83000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
82000 usd
us-gaap Deferred Tax Expense From Stock Options Exercised
DeferredTaxExpenseFromStockOptionsExercised
0 usd
us-gaap Deferred Tax Expense From Stock Options Exercised
DeferredTaxExpenseFromStockOptionsExercised
5000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-102000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
517000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
930000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-75000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
47000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
14000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
64000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
399000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-357000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
34000 usd
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
2240000 usd
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
3775000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
9878000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
10225000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
450000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
222000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
9000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-459000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-222000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
23000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
92000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2495000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
1060000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
2077000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3532000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1985000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-637000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-102000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5250000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7916000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60974000 usd
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
51590000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
66224000 usd
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
59506000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
2467000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
2279000 usd
us-gaap Interest Paid
InterestPaid
0 usd
us-gaap Interest Paid
InterestPaid
0 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
107138000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
19000 usd
CY2022Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
43000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-506000 usd
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1060000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
3534000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
109168000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4000 usd
CY2022Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
40000 usd
CY2022Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
-2495000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2298000 usd
CY2022Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1051000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
4103000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
107471000 usd
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
102822000 usd
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
89000 usd
CY2021Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
41000 usd
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-54000 usd
CY2021Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1039000 usd
CY2021Q1 us-gaap Profit Loss
ProfitLoss
3024000 usd
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
104883000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3000 usd
CY2021Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
41000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
49000 usd
CY2021Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1037000 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
3426000 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
107365000 usd
CY2022Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1622000 usd
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1468000 usd
CY2022Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
1290000 usd
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1398000 usd
CY2022Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
4426000 usd
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
3730000 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
7338000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
6596000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
40000 usd
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
41000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
83000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
82000 usd
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
0 usd
CY2022Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
0 usd
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3643000 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3646000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3649000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3645000 shares
CY2022Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
7000 shares
CY2021Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
9000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
9000 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.76
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13428000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25752000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
4103000 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
3426000 usd
us-gaap Profit Loss
ProfitLoss
7638000 usd
us-gaap Profit Loss
ProfitLoss
6450000 usd
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3650000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3655000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3658000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3656000 shares
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.13
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.94
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.09
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.77
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.12
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.94

Files In Submission

Name View Source Status
0001811884-22-000012-index-headers.html Edgar Link pending
0001811884-22-000012-index.html Edgar Link pending
0001811884-22-000012.txt Edgar Link pending
0001811884-22-000012-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
utmd-20220630.htm Edgar Link pending
utmd-20220630.xsd Edgar Link pending
utmd_ex31z1.htm Edgar Link pending
utmd_ex31z2.htm Edgar Link pending
utmd_ex32z1.htm Edgar Link pending
utmd_ex32z2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
utmd-20220630_def.xml Edgar Link unprocessable
utmd-20220630_pre.xml Edgar Link unprocessable
utmd-20220630_cal.xml Edgar Link unprocessable
utmd-20220630_lab.xml Edgar Link unprocessable
utmd-20220630_htm.xml Edgar Link completed